Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A uniqe antilipidemic drug--probucol.

× No keyword cloud information.

9 in total

Review 1. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors: Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal: Pharmacol Ther Date: 2012-07-20 Impact factor: 12.310

2. Protective effect of probucol on liver injury induced by carbon tetrachloride in rats.

Authors: Yu-Tao Zhan; Jing Weng; Li Li; Qing Xu; Xin Song; Xiao-Xia Guo
Journal: Hepatol Int Date: 2011-02-10 Impact factor: 6.047

3. Mechanisms underlying the inhibitory effects of probucol on elastase-induced abdominal aortic aneurysm in mice.

Authors: Cong Chen; Yunxia Wang; Yini Cao; Qinyu Wang; Gulinigaer Anwaier; Qingyi Zhang; Rong Qi
Journal: Br J Pharmacol Date: 2019-11-03 Impact factor: 8.739

4. Antioxidant and lipid-regulating effects of probucol combined with atorvastatin in patients with acute coronary syndrome.

Authors: Yu-Song Guo; Cai-Xia Wang; Jian Cao; Jin-Liao Gao; Xiao Zou; Yi-Hong Ren; Li Fan
Journal: J Thorac Dis Date: 2015-03 Impact factor: 2.895

5. Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.

Authors: Junhui Su; Cui Chang; Qi Xiang; Zhi-Wei Zhou; Rong Luo; Lun Yang; Zhi-Xu He; Hongtu Yang; Jianan Li; Yu Bei; Jinmei Xu; Minjing Zhang; Qihao Zhang; Zhijian Su; Yadong Huang; Jiyan Pang; Shu-Feng Zhou
Journal: Drug Des Devel Ther Date: 2014-12-12 Impact factor: 4.162

A uniqe antilipidemic drug--probucol.

Review 1. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

2. Protective effect of probucol on liver injury induced by carbon tetrachloride in rats.

3. Mechanisms underlying the inhibitory effects of probucol on elastase-induced abdominal aortic aneurysm in mice.

4. Antioxidant and lipid-regulating effects of probucol combined with atorvastatin in patients with acute coronary syndrome.

5. Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.

6. Successful treatment of diffuse normolipemic plane xanthoma with probucol.

7. Effect of probucol on insulin resistance in patients with non-diabetic chronic kidney disease.

8. Xanthine Oxidase Inhibition and Anti-LDL Oxidation by Prenylated Isoflavones from Flemingia philippinensis Root.

9. Mechanisms underlying probucol-induced hERG-channel deficiency.